Nizatidine (300 mg nocte) does not interfere with diazepam pharmacokinetics in man.
作者信息
Klotz U, Dammann H G, Gottlieb W R, Walter T A, Keohane P
出版信息
Br J Clin Pharmacol. 1987 Jan;23(1):105-6. doi: 10.1111/j.1365-2125.1987.tb03019.x.
Abstract
摘要
相似文献
1
Nizatidine (300 mg nocte) does not interfere with diazepam pharmacokinetics in man.尼扎替丁（每晚300毫克）不影响地西泮在人体中的药代动力学。
Br J Clin Pharmacol. 1987 Jan;23(1):105-6. doi: 10.1111/j.1365-2125.1987.tb03019.x.
2
Nizatidine, an H2-blocker. Its metabolism and disposition in man.尼扎替丁，一种H2受体阻滞剂。它在人体内的代谢与处置。
Drug Metab Dispos. 1986 Mar-Apr;14(2):175-82.
3
[Inhibition of 24-hour acidity by nizatidine].[尼扎替丁对24小时酸度的抑制作用]
Fortschr Med. 1989 May 10;107(14):321-4.
4
[Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Fortschr Med. 1989 Jul 20;107(21):467-70.
5
6
Lack of effect of nizatidine on hepatic drug metabolism in man.尼扎替丁对人体肝脏药物代谢无影响。
Br J Clin Pharmacol. 1985 Dec;20(6):710-3. doi: 10.1111/j.1365-2125.1985.tb05136.x.
7
Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.新型H2受体拮抗剂尼扎替丁的夜间抑酸作用
Hepatogastroenterology. 1986 Oct;33(5):217-20.
8
Intravenous nizatidine kinetics and acid suppression.静脉注射尼扎替丁的动力学及抑酸作用。
Clin Pharmacol Ther. 1985 Feb;37(2):162-5. doi: 10.1038/clpt.1985.29.
9
Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
Hepatogastroenterology. 1987 Dec;34(6):269-71.
10
Absorption studies of the H2-blocker nizatidine.
Clin Pharmacol Ther. 1987 Nov;42(5):514-20. doi: 10.1038/clpt.1987.190.
引用本文的文献
1
Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge.尼扎替丁，一种小分子化合物，可增强灭活H5N1疫苗的细胞介导反应，并保护小鼠免受致命病毒攻击。
Hum Vaccin Immunother. 2014;10(2):461-8. doi: 10.4161/hv.27165. Epub 2013 Nov 19.
2
Do nizatidine and cimetidine interact with ibuprofen?
Eur J Clin Pharmacol. 1988;35(1):85-8. doi: 10.1007/BF00555513.
3
Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.尼扎替丁。对其药效学和药代动力学特性及其在消化性溃疡疾病中的治疗应用的初步综述。
Drugs. 1988 Nov;36(5):521-39. doi: 10.2165/00003495-198836050-00002.
4
Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.新型H2受体拮抗剂。临床药代动力学及药物相互作用潜力。
Clin Pharmacokinet. 1988 Oct;15(4):205-15. doi: 10.2165/00003088-198815040-00001.
本文引用的文献
1
Lack of effect of nizatidine on hepatic drug metabolism in man.尼扎替丁对人体肝脏药物代谢无影响。
Br J Clin Pharmacol. 1985 Dec;20(6):710-3. doi: 10.1111/j.1365-2125.1985.tb05136.x.
2
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.年龄和肝脏疾病对成年男性体内地西泮处置与消除的影响。
J Clin Invest. 1975 Feb;55(2):347-59. doi: 10.1172/JCI107938.
Zotero 插件